Identification of the subcellular localization of daunorubicin in multidrug-resistant K562 cell line

被引:33
|
作者
Gong, YP [1 ]
Wang, YT [1 ]
Chen, FY [1 ]
Han, JY [1 ]
Miao, JM [1 ]
Shao, NX [1 ]
Fang, ZW [1 ]
Yang, RO [1 ]
机构
[1] Shanghai Second Med Univ, Leukemia Unit, Renji Hosp, Shanghai Inst Hematol, Shanghai 200001, Peoples R China
关键词
resistant k562 cell line; subcellular distribution; confocal laser scanning microscopy; P-glycoprotein;
D O I
10.1016/S0145-2126(00)00048-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We examined the subcellular distribution of daunorubicin (DNR) in resistant K562 cell line which overexpress the P-glycoprotein by confocal laser scanning microscopy. Three fluorescent probes - Rhodamine123, neutral red, NBD-ceramide, which stain the mitochondria, lysosomes, Golgi apparatus respectively, were used to identify the nature of the subcellular compartment sequestering daunorubicin. In sensitive k562 cell line, nuclear and cytoplasmic DNR fluorescence was intense and diffuse. In contrast, resistant K562 cell line showed a different DNR distribution. A bright fluorescence signal was located in the perinuclear region and peripheral plasma, the nucleus and other cytoplasmic region appear as empty, as suggested by the distribution of fluorescent probe Rhodamine123 specifically for mitochondria. Verapamil, an effective resistance modulator in P-glycoprotein MDR cells, restored the DNR distribution closer to that in the parent cells. Golgic inhibitor brefeldin A and lysosomotropic agent chloroquine had little effect on drug sequestration. Our studies demonstrate that daunorubicin may be sequestered in mitochondrial compartment in the resistant cells and P-glycoprotein plays an important role on mediating DNR transport. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:769 / 774
页数:6
相关论文
共 50 条
  • [41] INTRACELLULAR-LOCALIZATION, VESICULAR ACCUMULATION AND KINETICS OF DAUNORUBICIN IN SENSITIVE AND MULTIDRUG-RESISTANT GASTRIC-CARCINOMA EPG85-257 CELLS
    SEIDEL, A
    HASMANN, M
    LOSER, R
    BUNGE, A
    SCHAEFER, B
    HERZIG, I
    STEIDTMANN, K
    DIETEL, M
    VIRCHOWS ARCHIV, 1995, 426 (03) : 249 - 256
  • [42] The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems
    Cleary, I
    Doherty, G
    Moran, E
    Clynes, M
    BIOCHEMICAL PHARMACOLOGY, 1997, 53 (10) : 1493 - 1502
  • [43] In vitro antileukaemic activity of extracts from Daphne gnidium leaves against sensitive and multidrug resistant K562/R7 cells
    Chaabane, Fadwa
    Krifa, Mounira
    Matera, Eva
    Loussaeif, Amira
    Dijoux-Franca, Marie-Genevieve
    Ghedira, Kamel
    Dumontet, Charles
    Chekir-Ghedira, Leila
    TUMOR BIOLOGY, 2014, 35 (09) : 8991 - 8998
  • [44] The human KB multidrug-resistant cell line KB-C1 is hypersensitive to inhibitors of glycosylation
    Bentley, J
    Quinn, DM
    Pitman, RS
    Warr, JR
    Kellett, GL
    CANCER LETTERS, 1997, 115 (02) : 221 - 227
  • [45] Establishment of new multidrug-resistant human osteosarcoma cell lines
    Oda, Y
    Matsumoto, Y
    Harimaya, K
    Iwamoto, Y
    Tsuneyoshi, M
    ONCOLOGY REPORTS, 2000, 7 (04) : 859 - 866
  • [46] The effects of quercetin and kaempferol on multidrug resistance and the expression of related genes in human erythroleukemic K562/A cells
    Han Yanqiu
    Cao Linjuan
    Wu Jin
    Hao Hongjun
    Shi Yongjin
    Xu Guobin
    Ren Hanyun
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2011, 10 (62): : 13399 - 13406
  • [47] Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562
    Sargent, JM
    Williamson, CJ
    Yardley, C
    Taylor, CG
    Hellmann, K
    BRITISH JOURNAL OF CANCER, 2001, 84 (07) : 959 - 964
  • [48] Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562
    J M Sargent
    C J Williamson
    C Yardley
    C G Taylor
    K Hellmann
    British Journal of Cancer, 2001, 84 : 959 - 964
  • [49] Glucosylceramide synthase promotes Bcl-2 expression via the ERK signaling pathway in the K562/A02 leukemia drug-resistant cell line
    Wang, Qian
    Zou, Jian
    Zhang, Xiufen
    Mu, Huijun
    Yin, Ying
    Xie, Ping
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (06) : 559 - 566
  • [50] Computational and mechanistic studies on the effect of galactoxyloglucan: Imatinib nanoconjugate in imatinib resistant K562 cells
    James, Alphy Rose
    Unnikrishnan, B. S.
    Priya, R.
    Joseph, Manu M.
    Manojkumar, T. K.
    Pillai, K. Raveendran
    Shiji, R.
    Preethi, G. U.
    Kusumakumary, P.
    Sreelekha, T. T.
    TUMOR BIOLOGY, 2017, 39 (03)